New Zealand’s health authorities have introduced a nationwide system aimed at expediting assessment and treatment for people exhibiting symptoms of bowel cancer. The new protocol, launched by Health New Zealand Te Whatu Ora (HNZ) yesterday, seeks to reduce colonoscopy wait times by up to 30 percent through prioritising patients based on risk.

Bowel cancer remains the country’s second-leading cause of cancer-related deaths, accounting for more than 1,200 fatalities annually. Notably, early onset bowel cancer is increasing rapidly, with about 350 New Zealanders under the age of 50 diagnosed each year. Among these younger patients, a third present with late-stage, incurable disease. Bowel Cancer NZ estimates that approximately three people die from the disease daily.

Under the revised approach, general practitioners will issue faecal immunochemical tests (FIT) to symptomatic patients. The test detects blood levels in stool samples, allowing clinicians to categorise patients by urgency and prioritise specialist care accordingly. Those testing positive will be referred promptly for colonoscopy, while patients with negative results will continue to be monitored safely within primary care settings.

The programme, which underwent a two-year development period and was piloted in select regions, is designed to enhance early detection and improve access to timely treatment. Rachel Haggerty, HNZ’s director of hospital funding, highlighted the benefits, stating that the system helps alleviate patients’ anxiety by clarifying the need and urgency for further investigations. She added that it also provides reassurance for lower-risk individuals while establishing clearer care pathways.

Previously, GPs would refer symptomatic patients to outpatient specialists who conducted initial assessments to determine the urgency of care and placement on waitlists. The new model streamlines this process by employing the FIT test as a preliminary risk assessment tool. Despite this change, some patients with severe symptoms may still be referred directly to colonoscopy or specialist clinics without FIT testing.

This initiative complements the existing National Screening Programme, which offers free bowel cancer screening to asymptomatic individuals aged 58 to 74. Beginning September 30, eligibility will expand to include people aged 56 to 74. The combined efforts aim to reduce mortality and improve outcomes by identifying bowel cancer at earlier, more treatable stages.